Diamedica Therapeutics Inc. · NASDAQ:DMAC
John Fichthorn's stake in Diamedica Therapeutics Inc. fell to 0.30% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
John Fichthorn's stake in Diamedica Therapeutics Inc. fell to 0.30%, 153,983 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 0.30%
- Shares
- 153,983
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Dialectic Life Sciences SPV LLC | 0% | 0 |
| Dialectic LS Manager LLC | 0% | 0 |
| Dialectic Capital Management, LP | 0% | 0 |
| Dialectic Partners, LLC | 0% | 0 |
| John Fichthorn | 0.30% | 153,983 |
Source
Related
- Diamedica Therapeutics Inc.
- John Fichthorn
- Diamedica Therapeutics Inc. shareholders
- Form 4 · Pauls Dietrich John · Aug 12, 2026
- Schedule 13G/A · Cooperman Leon G · Feb 17, 2026
- Schedule 13G/A · Trill AB · Feb 6, 2026
- Schedule 13G/A · Richard Jacinto II · Nov 7, 2025
- Schedule 13G/A · Cooperman Leon G · Oct 15, 2025